MedTrace Logo

3 Days Amoxicillin Versus Placebo for Fast Breathing Childhood Pneumonia in Malawi

NCT02760420 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1126

Last updated 2021-02-18

No results posted yet for this study

Summary

The purpose of this study to assess the effectiveness of no antibiotic treatment for fast breathing, community-acquired childhood pneumonia in a malaria-endemic region of Malawi.

Conditions

Interventions

DRUG

Amoxicillin

Oral amoxicillin dispersible tablets (DT), 250 mg tablets, given according to age band, two times daily

DRUG

Placebo

Oral placebo dispersible tablets (DT), 250 mg tablets, given according to age band, two times daily

Sponsors & Collaborators

  • University of North Carolina

    collaborator OTHER

  • University of Washington

    collaborator OTHER

  • Save the Children

    lead OTHER

Principal Investigators

  • Amy Ginsburg, MD, MPH · Consultant, University of Washington

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2019-03-31
Completion
2019-06-30

Countries

  • Malawi

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02760420 on ClinicalTrials.gov